Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MUHAMED BALJEVIC

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1740507706
CMS profile
2777962
Location
NASHVILLE, TN

General Payments · PY2018–2024

$211,077.21

  • Reported across 111 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$113,368.76

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $84,525.00 4
GENZYME CORPORATION $18,433.37 9
ABBVIE INC. $3,723.19 2
PFIZER INC. $2,302.46 2
Janssen Biotech, Inc. $2,008.72 4
RECORDATI_RARE_DISEASES_INC. $893.00 1
Janssen Scientific Affairs, LLC $750.00 1
Karyopharm Therapeutics Inc. $321.40 4
Acerta Pharma LLC $174.42 1
Teleflex LLC $139.37 1
TAIHO ONCOLOGY, INC. $97.83 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,001.60 27
PY2019 $12,111.23 16
PY2020 $3,700.00 4
PY2021 $12,691.49 7
PY2022 $7,021.26 9
PY2023 $53,182.87 18
PY2024 $113,368.76 30

Payment records · PY2024 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $98.19 05/08/2024 Food and Beverage Undisputed 01/23/2026 1103271641 CMS
ABBVIE INC. $3,625.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1103131629 CMS
AstraZeneca Pharmaceuticals LP $174.42 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1104652285 CMS
GENZYME CORPORATION $44.50 06/13/2024 Food and Beverage Undisputed 01/23/2026 1139666150 CMS
GENZYME CORPORATION $167.17 07/11/2024 Food and Beverage Undisputed 01/23/2026 1139666206 CMS
GENZYME CORPORATION $270.07 07/11/2024 Travel and Lodging Undisputed 01/23/2026 1139666208 CMS
GENZYME CORPORATION $442.56 07/11/2024 Travel and Lodging Undisputed 01/23/2026 1139666210 CMS
GENZYME CORPORATION $9,972.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1139666212 CMS
GENZYME CORPORATION $2,909.00 07/11/2024 Consulting Fee Undisputed 01/23/2026 1139666214 CMS
GENZYME CORPORATION $1,662.00 10/29/2024 Consulting Fee Undisputed 01/23/2026 1139666242 CMS
GENZYME CORPORATION $57.07 12/06/2024 Food and Beverage Undisputed 01/23/2026 1139666248 CMS
GENZYME CORPORATION $2,909.00 12/06/2024 Consulting Fee Undisputed 01/23/2026 1139666250 CMS
GlaxoSmithKline, LLC. $37,800.00 01/25/2024 Consulting Fee Undisputed 01/23/2026 1116530226 CMS
GlaxoSmithKline, LLC. $21,525.00 04/29/2024 Consulting Fee Undisputed 01/23/2026 1116194113 CMS
GlaxoSmithKline, LLC. $4,375.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1116427014 CMS
GlaxoSmithKline, LLC. $20,825.00 10/28/2024 Consulting Fee Undisputed 01/23/2026 1116697599 CMS
Janssen Biotech, Inc. $137.86 08/10/2024 Food and Beverage Undisputed 01/23/2026 1078672218 CMS
Janssen Biotech, Inc. $75.86 08/11/2024 Food and Beverage Undisputed 01/23/2026 1078675258 CMS
Janssen Biotech, Inc. $1,755.00 11/01/2024 Consulting Fee Undisputed 01/23/2026 1078676373 CMS
Janssen Biotech, Inc. $40.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1078671222 CMS
Janssen Scientific Affairs, LLC $750.00 11/22/2024 Consulting Fee Undisputed 01/23/2026 1078291782 CMS
Karyopharm Therapeutics Inc. $126.78 04/15/2024 Food and Beverage Undisputed 01/23/2026 1145534231 CMS
Karyopharm Therapeutics Inc. $74.78 06/15/2024 Food and Beverage Undisputed 01/23/2026 1145534235 CMS
Karyopharm Therapeutics Inc. $70.25 09/28/2024 Food and Beverage Undisputed 01/23/2026 1145534239 CMS
Karyopharm Therapeutics Inc. $49.59 12/08/2024 Food and Beverage Undisputed 01/23/2026 1145534242 CMS
PFIZER INC. $102.46 09/27/2024 Food and Beverage Undisputed 01/23/2026 1131994785 CMS
PFIZER INC. $2,200.00 10/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1132064652 CMS
RECORDATI_RARE_DISEASES_INC. $893.00 05/03/2024 Consulting Fee Undisputed 01/23/2026 1139161186 CMS
TAIHO ONCOLOGY, INC. $97.83 09/30/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 1137943803 CMS
Teleflex LLC $139.37 05/16/2024 Food and Beverage Undisputed 01/23/2026 1142094783 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.